Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1AMLODIPINE AND OLMESARTAN MEDOXOMIL
02 3AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
03 1ARTHROTEC
04 1ASPIRIN AND DIPYRIDAMOLE
05 1BENAZEPRIL HYDROCHLORIDE
06 1BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
07 2BUPROPION HYDROCHLORIDE
08 1CEFUROXIME AXETIL
09 9CLOPIDOGREL BISULFATE
10 1COREG CR
11 1CYTOTEC
12 3DEFERASIROX
13 2DICLOFENAC SODIUM AND MISOPROSTOL
14 1DILACOR XR
15 4ISOSORBIDE MONONITRATE
16 1LEVETIRACETAM
17 1LOTENSIN
18 1LOTREL
19 2METFORMIN HYDROCHLORIDE
20 2MISOPROSTOL
21 1OLMESARTAN MEDOXOMIL
22 1OXYBUTYNIN CHLORIDE
23 1PLAVIX
24 1REQUIP XL
25 2ROPINIROLE HYDROCHLORIDE
26 1UROXATRAL
27 1VALACYCLOVIR HYDROCHLORIDE
28 1ZENPEP
29 2ZONISAMIDE
01 119268
02 119851
03 120092
04 120364
05 120607
06 120839
07 121287
08 122008
09 122012
10 122210
11 165166
12 175155
13 176402
14 176631
15 177135
16 177183
17 177215
18 177644
19 177869
20 178381
21 179226
22 190014
23 190494
24 190540
25 190598
26 190844
27 191023
28 191395
29 191430
30 191667
31 1200270
32 1200495
33 1200540
34 1201089
35 1201686
36 1202266
37 1202332
38 1202774
39 1202775
40 1202786
41 1202925
42 1203281
43 1203751
44 1204165
45 1204552
46 1207807
47 1210201
48 1210519
49 1210555
50 1213374
01 49No
02 1Yes
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Drug : PLAVIX
Dosage Form : TABLET; ORAL
Application Number : 20839
Country : US
Patented : No
Drug : DILACOR XR
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20092
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77183
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : ISOSORBIDE MONONITRATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90598
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 78381
Country : US
Patented : No
Drug : CLOPIDOGREL BISULFATE
Dosage Form : TABLET; ORAL
Application Number : 202925
Country : US
Patented : No
Drug : UROXATRAL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21287
Country : US
Patented : No
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
Drug : AMLODIPINE AND OLMESARTAN MEDOXOMIL
Dosage Form : TABLET; ORAL
Application Number : 207807
Country : US
Patented : No
Drug : OLMESARTAN MEDOXOMIL
Dosage Form : TABLET; ORAL
Application Number : 203281
Country : US
Patented : No
PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)
Drug : ZENPEP
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 22210
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
